Proteomic analysis for human urinary proteins associated with arsenic intoxication

Proteomics - Clinical Applications

Volumn 2, Issue 7-8, 2008, Pages 1087-1098

  Tan, Lia Beng ^a,b   Chen, Kow Tong ^b   Tyan, Yu Chang ^c,d   Liao, Pao Chi ^b   Guo, How Ran ^b  

^a St Joseph Hospital   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Arsenic; Biomarkers; Bladder cancer; Urine protein

Indexed keywords

ADAM PROTEIN; ADAM28 PROTEIN; ARSENIC; BIOLOGICAL MARKER; CALPAIN; CALPAIN 9; RING FINGER PROTEIN; RING FINGER PROTEIN 20;

ARSENIC POISONING; ARTICLE; BLADDER CARCINOMA; BLADDER TRANSITIONAL CELL CARCINOMA; CHEMICAL CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ELECTROSPRAY MASS SPECTROMETRY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LONG TERM EXPOSURE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TRANSITIONAL CELL CARCINOMA; URINALYSIS;

EID: 50849107042     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800021     Document Type: Article

References (43)

1. Fong, K., Lee, F., Bockrath, R., Effects of sodium arsenite on single strand DNA break formation and post-replication repair in E. coli following UV irradiation. Mutat. Res. 1980, 70, 151-156.
2. McCabe, M., Maguire, D., Nowak, M., The effects of arsenic compounds on human and bovine lymphocytes mitogenesis in vitro. Environ. Res. 1983, 31, 322-331.
3. Wu, H.-Y., Chen, K.-P., Tseng, W. P., Hsu, C.-L., Epidemiologic studies on blackfoot disease. 1: Prevalence and incidence of the disease by age, sex, year, occupation and geographical distribution. Mem. Coll. Med. Natl. Taiwan Univ. 1961, 7, 33-50.
4. Tseng, W.-P., Effects and dose-response relationship of skin cance and blackfoot disease with arsenic. Environ. Health Perspect. 1977, 19, 109-119.
5. Chen, C. J., Chuang, Y. C., Lin, T. M., Wu, H. Y., Malignant neaplasms among residents of a blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers. Cancer Res. 1985, 45, 5895-5899.
6. Chen, C.-J., Chen, C.-W., Wu, M.-M., Kuo, T. L., Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 1992, 66, 888-892.
7. Chen, C.-J., Chuang, Y.-C., Ysu, T.-M., Lin, T.-M., Wu, H.-Y., A retrospective study on malignant neoplasms of bladder, lung, liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer 1986, 53, 399-405.
8. Liaw, K.-F., Horng, S.-F., Lin, L.-J., Hsueh, Y.-M. et al., A cohort study on lower urinary tract cancers in the endemic area of blackfoot disease. Chin. J. Public Health 1995, 14, 23-31.
9. Chiuo, H.-Y., Chiou, S.-T., Hsu, Y.-H., Chou, Y.-L. et al., Incidence of transitional cell carcinoma and arsenic in drinking water: A follow-up study of 8,102residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 2001, 153, 411-418.
10. Guo, H.-R., Chiang, H.-S., Hu, H., Lipitz, S. R., Monson, R. R., Arsenic in drinking water and incidence of urinary cancers. Epidemiology 1997, 8, 545-550.
11. Mostofi, F. K., Davis, C. J., Sesterhenn, I. A.,Histological typing of urinary bladder tumors, in: International Histological Classification of Tumors. World Health Organization, Geneva 1998.
12. Greene, F. L., Page,D. L., Flemming, I. D., Fritz, A. G. et al., AJCC Cancer Staging Mannual 6th edn., Springer-Verlag, New York2002.
13. Health Department of Taiwan Provincial Government: Work discussion report for five-year plan for 4th term of Taiwan BFD prevention, 1991.
14. Health Department of Taiwan Provincial Government: Work discussion report for one year plain for 23rd term of Taiwan BFD prevention, 1997.
15. Yeh, S., How, S. W., A pathological study on the blackfoot disease in Taiwan. Rep. Inst. Pathol. Natl. Taiwan Univ. 1963, 14, 25-73.
16. Pieper, R., Gatlin, C. L., McGrath, A. M., Makusky, A. J. et al., Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004, 4, 1159-1174.
17. Bradford, M. M., A rapid and sensitive method for the quantities of protein. Anal. Biochem. 1976, 72, 248-254.
18. Heine, G., Raida, M., Forssmann, W. G., Mapping of peptides and protein fragments in human urine using liquid chromatography-mass spectrometry. J. Chromatogr. Anal. 1997, 776, 117-124.
19. Yates, J. R., Protein structure analysis by mass spectrometry. Methods Enzymol. 1996, 271, 351-377.
20. Tsuda, T., Babazono, A., Yamamoto, E., Kurumatani, N. et al., Ingested arsenic and internal cancer: A historical cohort study followed for 33 years. Am. J. Epidemiol. 1995, 141, 198-209.
21. Tsuda, T., Nagira, T., Yamamoto, M., Kume,Y., An epidemiology study on cancer in certified arsenic poisoning patients in Toroku. Ind. Health 1990, 28, 53-62.
22. Hopenhayn-Rich, C., Biggs, M. L., Fuchs, A., Bergoglio, R. et al., Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 1996, 7, 117-124.
23. Bates, M. N., Smith, A. H., Cantor, K. P., Case control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol. 1995, 147, 523-530.
24. Cuzick, J., Sasieni, P., Evans, S., Ingested arsenic, keratoses, and bladder cancer. Am. J. Epidemiol. 1992, 136, 417-421.
25. Luchtrath, H., The consequences of chronic arsenic poisoning among Moselle wine growers. Pathoanatomica investigations of post-mortem examinations performed between 1960-1977. J. Cancer Res. Clin. Oncol. 1983, 105, 173-182.
26. Howard, L., Maciewicz, R. A., Blobel, C. P., Cloning and characterization of ADAM28: Evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28. Biochem. J. 2000, 348, 21-27.
27. Seals, D. F., Courtneidge, S. A., The ADAMs family of metalloproteases: Multidomain proteins with multiple functions. Genes Dev. 2003, 17, 7-30.
28. Blobel, C. P., Key components in EDFR signaling and development. Nat. Rev. Mol. Cell Biol. 2005, 6, 32-43.
29. Mitsu, Y., Mochizuki, S., Kodama, T., Shimoda, M. et al., ADAM28 is overexpressed in human breast carcinomas: Implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3. Cancer Res. 2006, 20, 9913-9920.
30. Gerhardt, R., Hudson, J., Rao, R., Sobel, R., Chronic renal insufficiency from cortical necrosis induced by arsenic poisoning. Br. J. Ind. Med. 1978, 138, 267-269.
31. Hamamoto, E., Infant arsenic poisoning by powdered milk. Jpn. Med. J. 1955, 16, 2-12.
32. Huang, Y., Wang, K. K., The calpain family and human disease. Trends Mol. Med. 2001, 7, 355-362.
33. Kamei, M., Webb, G. C., Young, I. G., Campbell, H. D., SOLH, a human homologue of the Drosophila melanogaster small optic lobes gene is a member of the calpain and zinc-finger families and maps to human chromosome 16p13.3 near CATM (cataract with microphthalmia). Genomics 1998, 51, 197-206.
34. Yoshikawa, Y., Mukai, H., Hino, F., Asada, K., Kato, I., Isolation of two novel genes, down-regulated in gastric cancer. Jpn. J. Cancer Res. 2000, 91, 459-463.
35. Chiou, H.-Y., Hsueh, Y.-M., Liaw, F.-F., Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study in Taiwan. Cancer Res. 1995, 55, 1296-1300.
36. Lu, Z., Xu, S., Joazeiro, C., Cobb, M. H., Hunter, T., The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol. Cell 2002, 9, 945-956.
37. Swanswon, R., Locher, M., Hochstrasser, M., A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Mat2 repressor degradation. Genes Dev. 2001, 75, 2660-2674.
38. Wood, A., Krogan, N. J., Dover, J., Schmeoder, J. et al., BRE1, an E3 ubiquitin ligase required for recruitment and substract selection of RAD6 at a promoter. Mol. Cell 2003, 11, 267-274.
39. Kim, J., Hake, S. B., Roeder, R. G., The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions. Mol. Cell 2005, 20, 759-770.
40. Song, H.-Y., Association of a ring finger protein with the cytopalsmic domain of the human type-2 tumor necrosis factor receptor. Biochem. J. 1995, 309, 825-829.
41. Castilla, L. H., Couch, F. J., Erdos, M. R., Hoskins, K. F. et al., Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat. Genet. 1994, 8, 387-391.
42. Chen, C.-J., Wu, M.-M., Lee, S.-S., Wang, J.-D. et al., Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 1988, 8, 452-460.
43. Newmark, H. L., Yang, K., Lipkin, M., Kopelovich, L. et al., A Western-style diet induces benign and malignant neoplasma in the colon of normal C57BL/8 mice. Carcinogenesis 2001, 11, 871-875.